CD8A and neoplasm: To further explore the role of DC-SIGN (+) dendritic cells, we attempted to detect Siglec (CD169), a crucial molecule for the presentation of tumor-derived antigens, initiating early activation of tumor antigen-specific CD8 (+) T cells [24,25].